AU2018901782A0 - Chimeric Antigen Receptors with Modified Linker Domain and uses thereof - Google Patents

Chimeric Antigen Receptors with Modified Linker Domain and uses thereof

Info

Publication number
AU2018901782A0
AU2018901782A0 AU2018901782A AU2018901782A AU2018901782A0 AU 2018901782 A0 AU2018901782 A0 AU 2018901782A0 AU 2018901782 A AU2018901782 A AU 2018901782A AU 2018901782 A AU2018901782 A AU 2018901782A AU 2018901782 A0 AU2018901782 A0 AU 2018901782A0
Authority
AU
Australia
Prior art keywords
chimeric antigen
antigen receptors
linker domain
modified linker
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018901782A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carina Biotech Pty Ltd
Original Assignee
Carina Biotech Pty Ltd
Filing date
Publication date
Application filed by Carina Biotech Pty Ltd filed Critical Carina Biotech Pty Ltd
Publication of AU2018901782A0 publication Critical patent/AU2018901782A0/en
Priority to MX2020012445A priority Critical patent/MX2020012445A/en
Priority to EP19808128.3A priority patent/EP3797164A4/en
Priority to KR1020207033662A priority patent/KR20210013691A/en
Priority to CN201980034413.2A priority patent/CN112166193A/en
Priority to JP2020565274A priority patent/JP2021524248A/en
Priority to US17/057,060 priority patent/US20220089718A1/en
Priority to AU2019275479A priority patent/AU2019275479B2/en
Priority to SG11202010451QA priority patent/SG11202010451QA/en
Priority to BR112020023489A priority patent/BR112020023489A8/en
Priority to CA3099712A priority patent/CA3099712A1/en
Priority to PCT/AU2019/050487 priority patent/WO2019222796A1/en
Abandoned legal-status Critical Current

Links

AU2018901782A 2018-05-21 2018-05-21 Chimeric Antigen Receptors with Modified Linker Domain and uses thereof Abandoned AU2018901782A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
PCT/AU2019/050487 WO2019222796A1 (en) 2018-05-21 2019-05-20 Chimeric antigen receptors with modified linker domains and uses thereof
JP2020565274A JP2021524248A (en) 2018-05-21 2019-05-20 Chimeric antigen receptor with modified linker domain and its use
EP19808128.3A EP3797164A4 (en) 2018-05-21 2019-05-20 Chimeric antigen receptors with modified linker domains and uses thereof
KR1020207033662A KR20210013691A (en) 2018-05-21 2019-05-20 Chimeric antigen receptor with modified linker domain and uses thereof
CN201980034413.2A CN112166193A (en) 2018-05-21 2019-05-20 Chimeric antigen receptors with modified linker domains and uses thereof
MX2020012445A MX2020012445A (en) 2018-05-21 2019-05-20 Chimeric antigen receptors with modified linker domains and uses thereof.
US17/057,060 US20220089718A1 (en) 2018-05-21 2019-05-20 Chimeric antigen receptors with modified linker domains and uses thereof
AU2019275479A AU2019275479B2 (en) 2018-05-21 2019-05-20 Chimeric antigen receptors with modified linker domains and uses thereof
SG11202010451QA SG11202010451QA (en) 2018-05-21 2019-05-20 Chimeric antigen receptors with modified linker domains and uses thereof
BR112020023489A BR112020023489A8 (en) 2018-05-21 2019-05-20 CHIMERIC ANTIGEN RECEPTORS WITH MODIFIED BINDING DOMAINS AND USES THEREOF
CA3099712A CA3099712A1 (en) 2018-05-21 2019-05-20 Chimeric antigen receptors with modified linker domains and uses thereof

Publications (1)

Publication Number Publication Date
AU2018901782A0 true AU2018901782A0 (en) 2018-05-31

Family

ID=

Similar Documents

Publication Publication Date Title
EP3732191A4 (en) Enhanced chimeric antigen receptors and uses thereof
EP3615567A4 (en) Chimeric antibody/t-cell receptor constructs and uses thereof
EP3658163A4 (en) Enhanced chimeric antigen receptors and use thereof
EP3842462A4 (en) Bcma chimeric antigen receptor based on single domain antibody and use thereof
EP3797164A4 (en) Chimeric antigen receptors with modified linker domains and uses thereof
EP3820484A4 (en) Ror-1 specific chimeric antigen receptors and uses thereof
EP3564266A4 (en) Novel chimeric antigen receptor and use thereof
IL277078A (en) Anti-cd33 chimeric antigen receptors and their uses
IL279979A (en) Chimeric antigen receptors with bcma specificity and uses thereof
EP3740511A4 (en) A cd19-based chimeric antigen receptor and application thereof
EP3365364A4 (en) Antibody/t-cell receptor chimeric constructs and uses thereof
EP3827025A4 (en) Gd2-based chimeric antigen receptor and application thereof
EP3638300A4 (en) Fibronectin binding domain chimeric antigen receptors and methods of use thereof
EP3845244A4 (en) Anti-bcma single domain antibodies and application thereof
EP3802615A4 (en) Muc16 specific chimeric antigen receptors and uses thereof
EP3919515A4 (en) Chimeric antigen receptor and use thereof
EP3720882A4 (en) T-cells comprising two different chimeric antigen receptors and uses thereof
EP3755722A4 (en) Cd83-binding chimeric antigen receptors
EP3765078A4 (en) Anti-gucy2c chimeric antigen receptor compositions and methods
EP3902838A4 (en) Cd30-binding moieties, chimeric antigen receptors, and uses thereof
EP3793578A4 (en) Chimeric antigen receptors targeting cd37 and cd19
EP4013798A4 (en) Chimeric antigen receptors and uses thereof
EP3720481A4 (en) Anti-dclk1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof
EP3585403A4 (en) Tim3-binding chimeric antigen receptors
EP3595721A4 (en) Chimeric antigen receptors targeting cd37